Philippe Laramee is a seasoned professional in the fields of Health Economics and Outcomes Research (HEOR) and Market Access, with a strong focus on innovative approaches for assessing healthcare technologies. He is currently serving as the Co-Director for Doctorate Candidates’ PhD Thesis at Aix-Marseille Université, a position he has held since 2020. In this role, Philippe is dedicated to evaluating novel methodological approaches in Health Economics and Outcomes Research, specifically focusing on their acceptability by Health Technology Assessment (HTA) authorities. His contributions in this area have significantly impacted the development of innovative strategies for evaluating healthcare interventions, ensuring their effective integration into the market.

Prior to his current position, Philippe Laramee served as the International Director in Market Access, Pricing & HEOR for Innovative Oncology & Rare Diseases at Pierre Fabre Headquarters from 2017 to 2023. In this prestigious role, he demonstrated exceptional leadership and expertise in the field. His responsibilities included overseeing market access strategies, pricing initiatives, and Health Economics and Outcomes Research for innovative oncology and rare disease therapies. Philippe played a pivotal role in shaping the market landscape for these specialized treatments, contributing to the advancement of healthcare options for patients facing complex medical conditions.

His work at both Aix-Marseille Université and Pierre Fabre Headquarters highlights his commitment to fostering the next generation of researchers and his instrumental role in driving innovative solutions in healthcare.